Dermatologists' Perspectives on Skincare Routine Trends. [PDF]
Poelhekken M, van der Bent SAS.
europepmc +1 more source
MCI/MI and MI contact allergy remain persistent. In this analysis of the Danish market, 257 products containing MCI/MI or MI were identified, and 30 products were analysed. Two exceeded regulatory limits, while most complied, suggesting current limits may require further investigation. Created in BioRender. Pedersen, M. K.
Mathias Krogh Pedersen +9 more
wiley +1 more source
Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1-Contact Allergy to Baseline Series Allergens. [PDF]
Sukakul T +5 more
europepmc +1 more source
ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti +7 more
wiley +1 more source
Skin Sensitisation and Dermatitis Among Epoxy-Exposed Workers in a Wind Turbine Plant: Influence of Occupational Factors. [PDF]
Pinheiro V +9 more
europepmc +1 more source
Occupational Contact Urticaria, Protein Contact Dermatitis and Concomitant Airway Diseases in the Finnish Register of Occupational Diseases in 2005-2020: Main Causes and Occupations at Risk. [PDF]
Ojanen V +4 more
europepmc +1 more source
Patch Test Reactions to Dental Materials: A Retrospective Single‐Centre Study
In this retrospective single‐centre study of 439 adults referred for suspected delayed‐type hypersensitivity to dental materials, 50.1% had at least one positive patch test reaction, most often to metals. Nickel (23.0%) and palladium (16.6%) pre‐dominated, whilst methacrylate positivity was uncommon (6.2%) and not fully captured by HEMA alone.
Mojca Bizjak‐Suran +3 more
wiley +1 more source
Photodistributed exfoliative dermatitis associated with semaglutide: Expanding the spectrum of glucagon-like peptide-1 receptor agonist-associated cutaneous reactions. [PDF]
Kann R +5 more
europepmc +1 more source

